Safe Save Medical Cell Sciences & Technology Co.,Ltd.
1 clinical trials · Sponsor
◉ Watch Safe Save Medical Cell Sciences & Technology Co.,Ltd.
| Record | Firm | Date |
|---|---|---|
| ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM) (NCT04277221) | Safe Save Medical Cell Sciences & Technology Co.,Ltd. | 2019-09-19 |
Track Safe Save Medical Cell Sciences & Technology Co.,Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.